Weishi
Clinical trials sponsored by Weishi, explained in plain language.
-
Herbal extract shows promise for stiff skin and joints in transplant survivors
Disease control Recruiting nowThis study tests whether adding madecassoside tablets (from the Centella asiatica plant) to standard treatment can help people with a severe form of chronic graft-versus-host disease that causes skin hardening and joint stiffness. About 30 participants aged 14 to 65 will take the…
Phase: PHASE2 • Sponsor: WeiShi • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Immune-Guided drug timing could cut CMV prevention after transplant
Prevention Recruiting nowThis study tests a personalized approach to stopping the drug Letermovir, which prevents a common virus called CMV after a stem cell transplant. Instead of giving the drug for a fixed 100 days, doctors will use a blood test to see when a patient's own immune system has recovered …
Phase: PHASE4 • Sponsor: WeiShi • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC